Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

Journal of Clinical Oncology

Volumn 18, Issue 8, 2000, Pages 1652-1661

  Vokes, Everett E ^a   Kies, Merrill S ^a   Haraf, Daniel J ^a   Stenson, Kerstin ^a   List, Marcy ^a   Humerickhouse, Rod ^a   Eileen Dolan, M ^a   Pelzer, Harold ^a   Sulzen, Laura ^a   Witt, Mary Ellyn ^a   Hsieh, Yi Ching ^a   Mittal, Bharat B ^a   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CISPLATIN; FLUOROURACIL; HYDROXYUREA; RETINOIC ACID;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; HEAD CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK CANCER; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 17644448551     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.8.1652     Document Type: Article

References (47)

1. Vokes EE, Weichselbaum RR, Lippman S, et al: Head and neck cancer. N Engl J Med 328:184-194, 1993
2. Vokes EE, Athanasiadis I: Chemotherapy for head and neck cancers: The future is now. Ann Oncol 7:15-29, 1996
3. Hong WK, Lippman SM, Wolf GT: Recent advances in head and neck cancer: Larynx preservation and cancer chemoprevention - The Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 53:5113-5120, 1993
4. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
5. Lefebvre J-L, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial -EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899, 1996
6. Lefebvre JL, Wolf G, Luboinski B, et al: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (2) Larynx preservation using neoadjuvant chemotherapy (CT) in laryngeal and hypopharyngeal carcinoma. Proc Am Soc Clin Oncol 17:382a, 1998 (abstr 1473)
7. Paccagnell A, Orlando A, Marcniori C, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui tumori della Testa e del collo. J Natl Cancer Inst 86:265-272, 1994
8. Jacobs C, Makuch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 8:838-847, 1990
9. Lippman SM, Batsakis JG, Toth BB, et al: Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328:15-20, 1993
10. Jacobs C: The internist in the management of head and neck cancer. Ann Intern Med 113:771-778, 1990
11. Bourhis J, Pignon JP, Designe L, et al: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (1) Loco-regional treatment vs same treatment + chemotherapy (CT). Proc Am Soc Clin Oncol 17:386a, 1998 (abstr 1486)
12. Vokes EE, Weichselbaum RR: Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911-934, 1990
13. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 19:567-575, 1997
14. Browman GP, Cripps C, Hodson DI, et al: Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 12:2648-2653, 1994
15. Haffty BG, Son YH, Papac R, et al: Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials. J Clin Oncol 15:268-276, 1997
16. Merlano M, Benasso M, Corvo R, et al: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996
17. Wendt TG, Grabenbauer GG, Rodel CM, et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1324, 1998
18. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998
19. Al-Sarraf M, LeBlanc M, Giri PGS, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 16:1310-1317, 1998
20. Calais G, Alfonsi M, Bardet E, et al: Randomized study comparing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma (ARCORO): Preliminary results of the 94.01 study from the French Group of Radiation Oncology for Head and Neck Cancer (GORTC). Proc Am Soc Clin Oncol 17:385a, 1998 (abstr 1484)
21. Vokes EE, Weichselbaum RR, Mick R, et al: Favorable long-term survival following induction chemotherapy with PFL and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 84:877-881, 1992
22. Vokes EE, Kies M, Haraf DJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13:876-883, 1995
23. Kies MS, Haraf DJ, Athanasiadis I, et al: Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease-control and survival. J Clin Oncol 16:2715-2721, 1998
24. Vokes EE, Panje WR, Schilsky RL, et al: Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: A phase I-II study. J Clin Oncol 7:761-768, 1989
25. Haraf DJ, Kies MS, Rademaker AW, et al: Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer. J Clin Oncol 17:638-644, 1999
26. Byfield JE, Sharp TR, Frankel SS, et al: Phase I and II trial of five-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck. J Clin Oncol 2:406-413, 1984
27. Taylor SG IV, Murthy AK, Calderelli DD, et al: Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 7:846-856, 1989
28. Vokes EE, Haraf DJ, Mick R, et al: Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol 12:2351-2359, 1994
29. Lippman SM, Parkinson DR, Ittri LM, et al: 13-cis-retinoic acid and interferon a-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84:235-241, 1992
30. Cella DF, Tulsky DS, Gray G, et al: The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
31. Cella DF: Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (version 3). Chicago, IL, Rush Medical Center, 1994
32. List MA, Ritter-Sterr CA, Lansky SB: A performance status scale for head and neck cancer patients. Cancer 66:564-569, 1990
33. List MA, D'Antonio LL, Cella DF, et al: The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale: A study of utility and validity. Cancer 77:2294-2301, 1996
34. Browman GP, Levine MN, Hodson DI, et al: The Head and Neck Radiotherapy Questionnaire: A morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 11:863-872, 1993
35. List MA, Mumby P, Haraf D, et al: Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 6:274-284, 1997
36. List MA, Siston A, Haraf D, et al: Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination. J Clin Oncol 17:1020-1028, 1999
37. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
38. Humerickhouse RA, Dolan ME, Haraf DJ, et al: Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inhibitor, and oral 5-FU with radiation therapy in patients with recurrent or advanced head and neck cancer. Clin Cancer Res 5:291-298, 1999
39. Wong WW, Mick R, Haraf DJ, et al: Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 29:153-162, 1994
40. Keane TJ, Cummings BJ, O'Sullivan B, et al: A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 25:613-618, 1993
41. Kotwall C, Sako K, Razack MS, et al: Metastatic pattern in squamous cell cancer of the head and neck. Am J Surg 154:439-442, 1987
42. Brockstein B, Haraf D, Stenson K, et al: A phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. J Clin Oncol 16:735-744, 1998
43. Vokes EE, Pajak TF: Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer. Ann Oncol 9:471-474, 1998
44. Stenson KM, Pelzer H, Wenig BL, et al: Organ preservation after aggressive concomitant chemoradiotherapy (CRT) and post-treatment surgery: The feasibility of neck dissection. Fourth International Conference on Head and Neck Cancer, Toronto, Canada, July 28 to August 1, 1996 (abstr 677)
45. Etienne MC, Cheradame S, Fischel JL, et al: Response to fluorouracil therapy in cancer patients: The role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 13:1663-1670, 1995
46. Santini J, Milano G, Thyss A, et al: 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer. Br J Cancer 59:287-290, 1989
47. Vokes EE, Ratain MJ, Mick R, et al: Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 11:360-368, 1993